Keros Therapeutics, Inc. (KROS)
20.21
+0.08
(+0.40%)
USD |
NASDAQ |
Dec 19, 16:00
20.21
0.00 (0.00%)
After-Hours: 20:00
Keros Therapeutics Price: 20.21 for Dec. 19, 2025
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Eli Lilly & Co. | 1070.89 |
| Pfizer Inc. | 25.16 |
| Innoviva, Inc. | 20.00 |
| Ocugen, Inc. | 1.39 |
| Bionano Genomics, Inc. | 1.59 |
Price Related Metrics
| PE Ratio | 13.10 |
| PS Ratio | 3.330 |
| Price to Book Value | 0.8752 |
| Price to Free Cash Flow | 9.434 |
| Earnings Yield | 7.63% |
| Market Cap | 615.72M |
| Operating PE Ratio | 18.85 |
| Normalized PE Ratio | 13.10 |